MAPT and supranuclear palsy, progressive, 1: Despite the fact that pathological mechanisms, in experimental models of PSP, appears well delineated (including transmission of intracellular altered tau seed from cell to cell, up to a diffuse brain deposition, Gibbons et al., 2019), our capability to transfer these models into translational or pharmacological research for PSP remains elusive.